Comments
Loading...

Catalyst Pharmaceuticals

CPRXNASDAQ
Logo brought to you by Benzinga Data
$20.43
-0.01-0.05%
At Close: -
$20.43
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$34.00
Lowest Price Target1
$15.50
Consensus Price Target1
$26.56

Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock, Analyst Ratings, Price Targets, Forecasts

Catalyst Pharmaceuticals Inc has a consensus price target of $26.56 based on the ratings of 8 analysts. The high is $34 issued by Cantor Fitzgerald on March 22, 2024. The low is $15.5 issued by Roth Capital on August 24, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Citigroup, and Truist Securities on August 12, 2024, August 9, 2024, and August 9, 2024, respectively. With an average price target of $30.33 between HC Wainwright & Co., Citigroup, and Truist Securities, there's an implied 48.47% upside for Catalyst Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Mar
0
0
0
0
May
1
Jun
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Citigroup
Truist Securities
Oppenheimer
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Catalyst Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Catalyst Pharmaceuticals (CPRX) stock?

A

The latest price target for Catalyst Pharmaceuticals (NASDAQ:CPRX) was reported by HC Wainwright & Co. on August 12, 2024. The analyst firm set a price target for $30.00 expecting CPRX to rise to within 12 months (a possible 46.84% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Catalyst Pharmaceuticals (CPRX)?

A

The latest analyst rating for Catalyst Pharmaceuticals (NASDAQ:CPRX) was provided by HC Wainwright & Co., and Catalyst Pharmaceuticals maintained their buy rating.

Q

When was the last upgrade for Catalyst Pharmaceuticals (CPRX)?

A

There is no last upgrade for Catalyst Pharmaceuticals

Q

When was the last downgrade for Catalyst Pharmaceuticals (CPRX)?

A

The last downgrade for Catalyst Pharmaceuticals Inc happened on August 24, 2022 when Roth Capital changed their price target from $10 to $15.5 for Catalyst Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Catalyst Pharmaceuticals (CPRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Catalyst Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Catalyst Pharmaceuticals was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

Q

Is the Analyst Rating Catalyst Pharmaceuticals (CPRX) correct?

A

While ratings are subjective and will change, the latest Catalyst Pharmaceuticals (CPRX) rating was a maintained with a price target of $26.00 to $30.00. The current price Catalyst Pharmaceuticals (CPRX) is trading at is $20.43, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch